|
|
|
|
home > abstract > Roberts, Babcock, Breitbach et al.
|
|
 |
|
Roberts WN, Babcock
EA, Breitbach SA et al.
The Journal of Rheumatology,1996;23: 1001-1004
It is suggested
that the number of intra-articular injections should
be limited for a given joint. However, the authors suggest
that by suppressing the inflammation by means of intra-articular
corticosteroid injections may adequately slow cartilage
degradation in active rheumatoid arthritis. Using a
database of 1987 patients with rheumatic diseases, those
with rheumatoid arthritis (RA) who had received four
or more injections in an asymmetric pattern during a
year were reviewed. A cohort of 13 patients was used
in a five-year prospective study. The total number of
injections received was 1,622. Results showed that joints
that were heavily injected did not have increased joint
arthroplasty. Injecting joints frequently may provide
a degree of chondroprotection when the alternative is
continued disease activity.
|
© Johnson & Johnson Inc. 2001-2010
This site is published by McNeil Consumer Healthcare, division of Johnson & Johnson Inc.
which is solely responsible for its content. It is intended for visitors from Canada only.
See our Legal Notice and Privacy Policy
Last updated: September 03rd, 2007
|
|
|
| |
|
 |
 |
 |
| |
You may also find the case on rheumatoid arthritis (Mrs. B.) of interest.
|
 |
|
|
|
 |
|
|
|
|
|
 |
 |
 |
| |
arthritisU.com
pays special attention to various aspects of osteoarthritis
(OA) from epidemiology to clinical practice. |
 |
| |
more |
|
 |
|
|
|
|
|
 |
 |
 |
 |
 |
|
|
|